Insight

Applonia Rose/LinkedIn

Jan 11, 2025, 15:43

Applonia Rose: The high performing papers and insightful review articles published in TCRT during 2024

Applonia Rose, Managing Editor at Sage, shared a post on LinkedIn:

“Happy New Year everyone.

As we embark on another impactful year, I’m excited to share the high-performing papers and insightful review articles published in Technology in Cancer Research and Treatment (TCRT) during 2024.

These contributions highlight the latest advancements and in-depth analyses shaping progress in cancer research and treatment.

Research articles:

1. ‘Randomized Pilot Study of a Keratin-based Topical Cream for Radiation Dermatitis in Breast Cancer Patients‘

2. ‘PRADclass: Hybrid Gleason Grade-Informed Computational Strategy Identifies Consensus Biomarker Features Predictive of Aggressive Prostate Adenocarcinoma’

3. ‘EGFR-TKIs Combined with Allogeneic CD8+ NKT Cell Immunotherapy to Treat Patients with Advanced EGFR-Mutated Lung Cancer’

Must-read Review Articles:

1. ‘Laser Interstitial Thermotherapy (LITT) in Recurrent Glioblastoma: What Window of Opportunity for This Treatment?‘

2. ‘Targeting Receptor Tyrosine Kinases as a Novel Strategy for the Treatment of Triple-Negative Breast Cancer‘

3. ‘The Role of microRNAs in Hepatocellular Cancer: A Narrative Review Focused on Tumor Microenvironment and Drug Resistance‘

A huge thank you to our authors, reviewers, and Editorial Board members for their invaluable contributions to the journal’s success.

Explore the journal page here.

TCRT is committed to driving innovation and shaping the future of cancer research in 2025 and beyond.

We invite interested authors to explore our submission guidelines and contribute their cutting-edge research to TCRT.”

Jennifer Lovick, Executive Editor of Technology in Cancer Research and Treatment at Sage, also shared a post on LinkedIn:

“Thank you so much to Technology in Cancer Research and Treatment authors, reviewers, and Editorial Board members for their hard work and contributions to the journal in 2024.

In 2025, the journal team looks forward to continuing our efforts to support the research community through collaboration with authors, reviewers, and the Editorial Board.

Authors interested in contributing to Technology in Cancer Research and Treatment can learn more about the journal and how to prepare a submission here.

More posts featuring Jennifer Lovick.